Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 506 followers
Latest posts
Last updated 9 days ago
Human medicines European public assessment report (EPAR): Wayrilz, rilzabrutinib, Status: Opinion
9 days ago
Human medicines European public assessment report (EPAR): Wayrilz, rilzabrutinib, Status: Opinion
Human medicines European public assessment report (EPAR): Rezurock, Belumosudil, Status: Opinion
9 days ago
Human medicines European public assessment report (EPAR): Rezurock, Belumosudil, Status: Opinion
Human medicines European public assessment report (EPAR): Brinsupri, Brensocatib, Status: Opinion
9 days ago
Human medicines European public assessment report (EPAR): Brinsupri, Brensocatib, Status: Opinion
Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Status: Opinion
Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Status: Opinion
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Status: Opinion
Human medicines European public assessment report (EPAR): Degevma, denosumab, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Degevma, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Status: Opinion
Human medicines European public assessment report (EPAR): Acvybra, denosumab, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Acvybra, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Denosumab Intas, denosumab, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Denosumab Intas, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Status: Opinion